Anuncia Medical, Inc.

Anuncia Medical is a neuro therapeutic device company currently solving the large unmet need in cerebrospinal fluid (CSF) management and neurocritical care of repeat revision brain surgeries by developing technology to monitor, treat, and prevent shunt occlusions at-home or in-clinic with clinically validated, noninvasive, ‘Breakthrough’ devices. Conceptualized in 2014 in collaboration with Boston Children’s Hospital and spun out of Alcyone Therapeutics in 2018, Anuncia’s patented portfolio of technologies are intended to provide peace-of-mind through innovation. Our core ReFlow technology uses a simple finger depression of a soft silicone dome located under the patient’s scalp to produce a noninvasive, one-way flush of the patient’s own CSF directed toward the ReFlow catheter to restore or increase CSF flow through a non-flowing shunt and potentially avoid emergency surgery.